EMBC
Embecta Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$5.80
+1.93%Leverage
- Debt / equity
- -2.45x
- Net debt / equity
- -2.10x
- Debt / assets
- 1.19x
- Debt / EBITDA
- 5.49x
- Net debt / EBITDA
- 4.70x
Liquidity & coverage
- Current ratio
- 1.68x
- Quick ratio
- 1.68x
- Cash ratio
- 0.51x
- Interest coverage
- 2.62x
- EBITDA / interest
- 2.83x
- Working capital
- $285.3M
Cash & dividend
- FCF / debt
- 0.11x
- Cash flow / debt
- 0.12x
- Dividend per share
- $0.32
- Dividend yield
- 5.5%
- Dividend growth 1y
- +0.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026